Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cytraben (also marketed as Citrabone) is a consumer dietary supplement developed and manufactured by Arian Salamat Sina in collaboration with Holistica Laboratories. It is formulated to support bone and joint health, prevent osteoporosis, and maintain bone density, particularly in postmenopausal women, elderly individuals, and those with calcium deficiencies. The supplement contains calcium citrate, which offers superior absorption compared to calcium carbonate and does not require an acidic stomach environment, making it highly suitable for individuals taking antacids or those with low stomach acid. It is co-formulated with marine magnesium, which supports muscle function and calcium metabolism, and natural vitamin D3 (cholecalciferol) to optimize calcium absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cytraben.